The longitudinal study of morphometric measurement changes in progressive supranuclear palsy

Area of Science:

• Neurology
• Radiology
• Neuroimaging

Background:

• Midbrain atrophy is a key indicator of progressive supranuclear palsy (PSP) disease severity.
• Midbrain-based Magnetic Resonance Parkinsonism Index (MRPI) measurements show promise as diagnostic biomarkers for PSP.

Purpose of the Study:

• To investigate longitudinal changes in MRPI measurements in PSP patients.
• To assess the association between MRPI measurements and PSP disease progression.

Main Methods:

• Quantitative morphometric measurements of the midbrain were performed.
• Annual percentage changes in MRPI measurements were calculated.
• Associations between baseline measurements and PSP rating scale scores were evaluated.

Main Results:

• Patients with PSP exhibited significant differences in baseline midbrain morphometric measurements compared to healthy controls (excluding the pons).
• Baseline MRPI measurements were significantly correlated with baseline PSP rating scale scores.
• Longitudinal MRPI measurements were analyzed for disease progression.

Conclusions:

• Midbrain-based MRPI measurements are sensitive to changes in PSP.
• MRPI measurements demonstrate potential as reliable biomarkers for monitoring PSP disease progression.